1 04, 2015 Giovanna De Maglio et al., MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology Diatech Pharmacogenetics2017-08-08T15:12:19+02:00 Leggi di più
1 04, 2015 Giulia Cini et al., Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family. Carcinogenesis Diatech Pharmacogenetics2017-08-08T12:23:51+02:00 Leggi di più
9 03, 2015 Elisa Chiadiniet al., EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab. Oncology Letters Diatech Pharmacogenetics2017-08-08T14:23:51+02:00 Leggi di più
1 02, 2015 Luisa Foltran et al., Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer. Future Oncology Diatech Pharmacogenetics2017-08-08T15:29:58+02:00 Leggi di più
1 02, 2015 Iris Zalaudek et al., A novel BRAF mutation in association with primary amelanotic melanoma with oral metastases. Journal of the European Academy of Dermatology and Venereology Diatech Pharmacogenetics2017-08-08T14:44:56+02:00 Leggi di più
1 02, 2015 Nora Sahnane et al., Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity. Endocrine-Related Cancer Diatech Pharmacogenetics2017-08-08T14:36:06+02:00 Leggi di più
26 01, 2015 Laura Boldrini et al., P2X7 mRNA expression in non?small cell lung cancer: MicroRNA regulation and prognostic value. Oncology Letters Diatech Pharmacogenetics2017-08-08T14:54:34+02:00 Leggi di più
12 12, 2014 Esther Diana Rossiet al., Morphological parameters able to predict BRAFV600E-mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience. Cancer Cytopathology Diatech Pharmacogenetics2017-08-08T15:48:14+02:00 Leggi di più
24 11, 2014 Marco Chilosi et al., Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis. Leukemia & Lymphoma Diatech Pharmacogenetics2017-08-08T16:16:33+02:00 Leggi di più
11 10, 2014 Virginia Rotella et al., EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition. Journal of Experimental & Clinical Cancer Research Diatech Pharmacogenetics2022-04-20T12:44:33+02:00 Leggi di più
